The dual double-doses of the Oxford vaccine were in error. That’s because administrators should have given a half followed by a full one. None the less, the improved results with the correct formula posed two interesting questions. First, did the first full dose cause the body to become immune to the follow-up in some cases? And secondly, will trialing two different vaccines together be even better?
Will Trialing Oxford and Sputnik Vaccines Together Be Better
Scientists suspect that theory will be more likely to hold, if the two vaccines are of the same family. In the case of the Oxford and Sputnik vaccines, both are viral vector versions that deliver a small piece of the coronavirus’ genetic code to the body. This could give the body an opportunity to develop defenses, without exposure to the COVID-19 illness.
AstraZeneca, who is driving the Oxford vaccine project is intrigued by the question will trialing two vaccines together be better. It is therefore working with industry partners, governments, and research institutions around the world according to BBC. And it will soon share ideas with Gamaleya Research Institute in Russia. In order to find out whether their two adenovirus-based vaccines could combine successfully.
This International Cooperation Could Be a Positive Sign
The World Health Organization WHO previously called for international cooperation on April 16, 2020, as the resilience of the virus emerged. It pledged to ‘continue efforts to strengthen the unprecedented worldwide collaboration, cooperation and sharing of data already underway.’
That’s because ‘those efforts will help reduce inefficiencies and duplication of effort, and WHO will work tenaciously to increase the likelihood that one or more safe and effective vaccines will soon be made available to all.’
We therefore support this effort to move on from Cold War rivalries, towards a better, disease-free life for all. If trialing two vaccines together could be an improvement for us all, then let’s at least give it a try.
Related
What We Do Know About the Russian Vaccine
The Facts and Potential of the Oxford Vaccine
Preview Image: Candidate Vaccine mRNA-1273
World Health Organization Call
s
